Clinical Trial

NPI-002 Intravitreal Implant for the Delay of Cataract Progression

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-08-24; most recent amendment 2026-04-08.
Status change: Recruiting → Active, Not Recruiting 2026-04-08
Status change: Not Yet Recruiting → Recruiting 2022-03-01
Trial Details
NCT Number NCT05026632
Lead Sponsor Nacuity Pharmaceuticals, Inc.
Conditions Cataract
Enrollment 30 participants
Start Date 2022-01-27
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-04-13